4 years ago
Psilocybin for major depression granted Breakthrough Therapy by FDA
The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).
Continue Reading
https://newatlas.com
Join the Discussion